POU Class 2 Homeobox 3 (POU2F3) Peptid
POU2F3
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN982004
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für POU Class 2 Homeobox 3 (POU2F3) Peptid (ABIN982004)
Target
POU2F3
(POU Class 2 Homeobox 3 (POU2F3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-POU2F3 antibody (Catalog #: ARP32537_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- POU2F3 (POU Class 2 Homeobox 3 (POU2F3))
-
Hintergrund
-
POU domain genes encode a family of highly conserved transacting factors that influence the transcriptional activity of several cell type-specific and ubiquitous genes. Studies have cloned and sequenced cDNAs encoding a novel mouse POU domain protein, Oct-11, that is closely related within the POU domain to the POU class II proteins, Oct-1 and Oct-2.
Alias Symbols: PLA1, OCT11, PLA-1, Epoc-1, OCT-11, OTF-11, Skn-1a
Protein Interaction Partner: CREBBP
Protein Size: 436 -
Molekulargewicht
- 47 kDa
-
Gen-ID
- 25833
-
NCBI Accession
- NM_014352, NP_055167
-
UniProt
- Q9UKI9
Target
-
Sie sind hier:
